Literature DB >> 6139140

Alpha 1 antagonistic and antiserotoninergic action during administration of ketanserin.

J Vermylen, R Fiocchi, R Fagard, P Lijnen, J Staessen, A Amery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6139140      PMCID： PMC1549935          DOI： 10.1136/bmj.287.6404.1551-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.

Authors:  H O Kalkman; P B Timmermans; P A Van Zwieten
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

2.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Authors:  J M Van Nueten; P A Janssen; J Van Beek; R Xhonneux; T J Verbeuren; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030
  2 in total
  2 in total

Review 1.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

2.  Response to tilting in hypertensive patients receiving ketanserin.

Authors:  L A Ferrara; F Pasanisi; M L Fasano; S Soro
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.